Xiaoxia Xing

548 total citations
9 papers, 394 citations indexed

About

Xiaoxia Xing is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Xiaoxia Xing has authored 9 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Xiaoxia Xing's work include Cancer, Hypoxia, and Metabolism (3 papers), Microbial metabolism and enzyme function (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Xiaoxia Xing is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Microbial metabolism and enzyme function (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Xiaoxia Xing collaborates with scholars based in China, Ethiopia and India. Xiaoxia Xing's co-authors include Jiefeng Cui, Rongxin Chen, Zhenggang Ren, Dongmei Gao, Yan Zhao, Sifan Wu, Yang You, Yaohui Wang, Miao Li and Zhiming Wang and has published in prestigious journals such as European Journal of Cancer, Cancer Letters and FEBS Journal.

In The Last Decade

Xiaoxia Xing

9 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxia Xing China 8 187 127 108 96 90 9 394
Tracey Amanda Martin United Kingdom 11 265 1.4× 168 1.3× 86 0.8× 111 1.2× 48 0.5× 15 478
Stéphanie Duhamel Canada 10 243 1.3× 159 1.3× 70 0.6× 72 0.8× 114 1.3× 18 448
Mattia Falcone Netherlands 9 220 1.2× 110 0.9× 76 0.7× 85 0.9× 55 0.6× 13 374
Reetta Virtakoivu Finland 11 282 1.5× 214 1.7× 150 1.4× 74 0.8× 165 1.8× 19 578
Dror Alishekevitz Israel 11 269 1.4× 270 2.1× 95 0.9× 103 1.1× 191 2.1× 16 556
Jelena Stanisavljević Spain 7 224 1.2× 196 1.5× 67 0.6× 72 0.8× 42 0.5× 8 377
Irene García‐Palmero Spain 12 249 1.3× 131 1.0× 57 0.5× 102 1.1× 65 0.7× 14 415
Ruchika Srinivasan United States 6 324 1.7× 122 1.0× 43 0.4× 103 1.1× 119 1.3× 6 481
Yukihiro Shiraki Japan 11 165 0.9× 135 1.1× 28 0.3× 79 0.8× 63 0.7× 29 354
Maria C. Cuitiño United States 9 240 1.3× 186 1.5× 60 0.6× 75 0.8× 59 0.7× 16 445

Countries citing papers authored by Xiaoxia Xing

Since Specialization
Citations

This map shows the geographic impact of Xiaoxia Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxia Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxia Xing more than expected).

Fields of papers citing papers by Xiaoxia Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxia Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxia Xing. The network helps show where Xiaoxia Xing may publish in the future.

Co-authorship network of co-authors of Xiaoxia Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxia Xing. A scholar is included among the top collaborators of Xiaoxia Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxia Xing. Xiaoxia Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Li, Miao, Xi Zhang, Mimi Wang, et al.. (2022). Activation of Piezo1 contributes to matrix stiffness‐induced angiogenesis in hepatocellular carcinoma. Cancer Communications. 42(11). 1162–1184. 93 indexed citations
2.
Chen, Shiping, Gui‐Qi Zhu, Xiaoxia Xing, et al.. (2022). LncRNA USP2-AS1 Promotes Hepatocellular Carcinoma Growth by Enhancing YBX1-Mediated HIF1α Protein Translation Under Hypoxia. Frontiers in Oncology. 12. 882372–882372. 11 indexed citations
3.
Wang, Biao, Jie Li, Lina Song, et al.. (2022). MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy. Cancer Letters. 541. 215750–215750. 17 indexed citations
4.
Xing, Xiaoxia, Nina Wietek, Kay Y. Chong, et al.. (2022). Investigation of the Potential Mechanisms Underlying Nuclear F-Actin Organization in Ovarian Cancer Cells by High-Throughput Screening in Combination With Deep Learning. Frontiers in Cell and Developmental Biology. 10. 869531–869531. 4 indexed citations
5.
Wu, Sifan, Xiaoxia Xing, Yaohui Wang, et al.. (2021). The pathological significance of LOXL2 in pre-metastatic niche formation of HCC and its related molecular mechanism. European Journal of Cancer. 147. 63–73. 37 indexed citations
6.
Xing, Xiaoxia, Yaohui Wang, Xi Zhang, et al.. (2020). Matrix stiffness‐mediated effects on macrophages polarization and their LOXL2 expression. FEBS Journal. 288(11). 3465–3477. 63 indexed citations
7.
Gao, Xiangyu, Xiaona Qiao, Xiaoxia Xing, et al.. (2020). Matrix Stiffness-Upregulated MicroRNA-17-5p Attenuates the Intervention Effects of Metformin on HCC Invasion and Metastasis by Targeting the PTEN/PI3K/Akt Pathway. Frontiers in Oncology. 10. 1563–1563. 41 indexed citations
8.
Wang, Yaohui, Xi Zhang, Weimin Wang, et al.. (2020). Integrin αVβ5/Akt/Sp1 pathway participates in matrix stiffness-mediated effects on VEGFR2 upregulation in vascular endothelial cells.. PubMed. 10(8). 2635–2648. 16 indexed citations
9.
Wu, Sifan, Qiongdan Zheng, Xiaoxia Xing, et al.. (2018). Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation. Journal of Experimental & Clinical Cancer Research. 37(1). 99–99. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026